Edwards wins over Japanese reimbursement gatekeepers
This article was originally published in Clinica
Executive Summary
Edwards Lifesciences will see its next-generation transcatheter aortic valve implantation (TAVI) system, Sapien XT, reimbursed in Japan from 1 October, following approval from the country’s Central Social Insurance Medical Council.